𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Receptor-binding conformation of the “ELR” motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 Å resolution

✍ Scribed by Nancy Gerber; Henry Lowman; Dean R. Artis; Charles Eigenbrot


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
497 KB
Volume
38
Category
Article
ISSN
0887-3585

No coin nor oath required. For personal study only.

✦ Synopsis


The "ELR" (Glu-Leu-Arg) tripeptide sequence near the N-terminus of interleukin-8 (IL-8) contributes a large part of the receptor binding free energy. Prior X-ray and nuclear magnetic resonance (NMR) structures of IL-8 have shown this region of the molecule to be highly mobile. We reasoned that a hydrophobic interaction between the leucine and the neighboring ␤-turn might exist in the receptor binding conformation of the Nterminus. To test this hypothesis, we mutated two residues to cysteine and connected the N-terminus to the ␤-turn. The mutant retains receptor binding affinity reasonably close to wild type and allows the characterization of a high-affinity conformation that may be useful in the design of small IL-8 mimics. The L5C/H33C mutant is refined to R-values of R ‫؍‬ 20.6% and R free ‫؍‬ 27.7% at 2.35 Å resolution. Other receptor binding determinants reside in the "N-loop" found after "ELR" and preceding the first ␤-strand. All available structures of IL-8 have been found with one of two distinct N-loop conformations. One of these is relevant for receptor binding, based on NMR results with receptor peptides. The other conformation obscures the receptor-peptide binding surface and may have an undetermined but necessarily different function.


📜 SIMILAR VOLUMES


Structural change and receptor binding i
✍ Charles Eigenbrot; Henry B. Lowman; Linda Chee; Dean R. Artis 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

The characteristic CXC chemokine disulfide core of interleukin-8 (IL-8) has been rearranged in a variant replacing the 9-50 disulfide with a 9-38 disulfide. The new variant has been characterized by its binding affinity to IL-8 receptors A and B and the erythrocyte receptor DARC. This variant binds